50242-064 : Tarceva 150 mg Oral Tablet


NDC50242-064
Labeler: Genentech, Inc.
Product Type: Human Prescription Drug
Drug Name:  Tarceva
Dosage Form: Oral Tablet
Application #: NDA021743
Rev. Date: 


Appearance:


Markings: T;150
Shapes:  Round
Colors:  White
Size (mm): 10
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

T 150: (50242-064) Tarceva 150 mg Oral Tablet by Genentech, Inc.
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 50242-064-01: 30 TABLET IN 1 BOTTLE (50242‑064‑01)

Active Ingredients:

  • Erlotinib Hydrochloride

Dosage Strength:

  • 150 mg

Pharmaceutical Classes:

  • Kinase Inhibitor [EPC]
  • Protein Kinase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 50242-062 Tarceva 25 mg Oral Tablet by Genentech, Inc.
  • 50242-063 Tarceva 100 mg Oral Tablet by Genentech, Inc.
  • 54868-5290 Tarceva 25 mg Oral Tablet by Physicians Total Care, Inc.
  • 54868-5447 Tarceva 150 mg Oral Tablet by Physicians Total Care, Inc.
  • 54868-5474 Tarceva 100 mg Oral Tablet by Physicians Total Care, Inc.
  • 69189-0063 Tarceva 100 mg Oral Tablet by Avera Mckennan Hospital

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50242-064 QR Code

< Prev: 50242-063Next: 50242-070 >

Related Discussions:

Tarceva hair
Has anyone tried keratin treatment on Tarceva effected hair? I was on Tarceva 18 mos and the hair is so unmanageable ## ... 2 replies
h 86, Tarceva, Soursop
My mom just recently got diagnose with stage 4 lung cancer and I'm trying to figure out if H-86 is similar to a medi... 4 replies
Side Effects of Tarceva -
Anyone have side effect of painful, bulging fingernails and nails coming off? ## That is not something that's listed... 1 reply
Tarceva 150mg
lung cancer ## This is Elotinib, used to treat small cell lung cancer.... 1 reply




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2015.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA